The first and only clinically validated gene expression test that objectively quantifies the likelihood of obstructive CAD in a stable chest pain patient.

The complex nature of cardiovascular disease and genomic testing demands rigor in both clinical studies and research methodologies.

Completion of the Human Genome Project in 2003 has ushered in the era of genomic medicine, and with it, the potential of more individualized patient care.